Today: 12 May 2026
Alphabet GOOG stock price rises on Meta AI chip deal, then slips after hours amid new Google ads probe
28 February 2026
2 mins read

Alphabet GOOG stock price rises on Meta AI chip deal, then slips after hours amid new Google ads probe

New York, Feb 27, 2026, 17:37 EST — After-hours

Alphabet Inc’s class C shares (GOOG.O) rose 1.4% to $311.43 on Friday after a report that Meta Platforms signed a multi-year, multi-billion-dollar deal to rent Google’s AI chips. Shares were last down about 0.5% at $309.90 in after-hours trading, the extended session after U.S. markets close.

The chip headline lands in a market still jumpy about where artificial intelligence ends up helping profits — and where it just rewires old business models. “There continues to be this … back and forth about who might be the victim and those that will actually emerge winners,” Kristina Hooper, chief market strategist at Man Group, said. Reuters

Regulators, meanwhile, keep poking at Google’s biggest money-maker. Belgium’s competition watchdog opened an investigation into the sale of online ads by Google, saying it had “serious indications” that the model for selling online ads was in breach of antitrust rules and that the company appeared to be abusing its market power. The authority said the probe was in a preliminary phase and the outcome was unclear. Reuters

The Information reported Meta would rent Google’s Tensor Processing Units, or TPUs — custom chips used to train and run artificial intelligence models, typically through Google’s cloud. Google has been pitching TPUs as an alternative to Nvidia’s GPUs, or graphics processing units, the workhorse chips for AI computing.

Wall Street’s tone did not help. The S&P 500 fell 0.43% on Friday and the Nasdaq dropped 0.92%, while Nvidia slid 3.5% as investors debated whether AI winners have already priced in years of growth. “They have priced in a lot of good news. And now it’s time for a breather,” said Talley Leger, chief market strategist at The Wealth Consulting Group. Reuters

Alphabet also outperformed some megacap peers on a down day. Microsoft fell 2.24% and Meta dropped 1.34%, while Amazon rose 1.0%, according to MarketWatch. Alphabet’s trading volume climbed to about 33 million shares, above its 50-day average of about 21.8 million.

GOOG traded between $303.59 and $312.08 on Friday. The stock’s 52-week range is $142.66 to $350.15, according to Investing.com.

Some of the sensitivity traces back to Alphabet’s own spending plans. Earlier this month, the company said 2026 capital expenditure could as much as double as it deepens investment to ease compute constraints and push ahead in the AI race; it forecast capex of $175 billion to $185 billion for 2026.

Alphabet also said on Feb. 4 its board declared a quarterly cash dividend of $0.21 per share, payable on March 16 to stockholders of record on March 9 for its Class A, B and C shares.

But the path is messy. A tougher regulatory hit to Google’s ad machinery would land where Alphabet still makes most of its money, and could force business changes that show up slowly in margins. At the same time, a wider pullback in AI spending — or a shift in who supplies the compute — would test the bullish case around chips and cloud.

Investors will also have one big macro number to digest before the next week gets going. The U.S. Employment Situation report for February is scheduled for release on Friday, March 6, at 8:30 a.m. ET.

For Alphabet, traders will be watching for any follow-through on TPU demand and for signs Europe’s ad probes are turning from process into penalties. March 6 and the March 9 dividend record date are the next marks on the calendar.

Stock Market Today

  • Eli Lilly Stock Forecast 2026: Price Target Set at $1,085 Amid Strong Q1 Growth
    May 12, 2026, 12:07 PM EDT. Eli Lilly's stock trades at $948.45 with a 24/7 Wall St. price target of $1,085, implying 14.3% upside. After a robust Q1 report featuring $19.80 billion revenue and $8.55 EPS, the drug Mounjaro became the world's best-selling, driving investor confidence. Bulls highlight Foundayo's oral GLP-1 innovation and retatrutide's promising Phase 3 data, with targets climbing as high as $1,400. However, pricing pressure and heavy reliance on Mounjaro and Zepbound revenue present risks. Management's raised guidance to $82-$85 billion boosts the buy thesis, but share sales by insiders and price erosion keep bears cautious. The 70% confidence rating reflects cautious optimism amid evolving market dynamics.

Latest article

Hims & Hers’ GLP-1 Reset Hits the Stock as Investors Reprice Growth Quality

Hims & Hers’ GLP-1 Reset Hits the Stock as Investors Reprice Growth Quality

12 May 2026
Hims & Hers Health shares fell 14.6% to $24.89 Tuesday after a Q1 net loss of $92.1 million, reversing a $49.5 million profit a year ago. Revenue rose 4% to $608.1 million, but gross margin dropped to 65% from 73% as the company shifted from compounded GLP-1s to branded drugs like Wegovy and Ozempic. Subscribers climbed to 2.584 million, while monthly revenue per subscriber slipped to $80.
POET Stock Rebounds as New COO Gives AI-Photonics Rally a Fresh Test

POET Stock Rebounds as New COO Gives AI-Photonics Rally a Fresh Test

12 May 2026
POET Technologies named Sandeep Kumar as chief operating officer, triggering a 2.95% stock rise to $14.31 on heavy volume after shares hit $15.15 intraday. Kumar, formerly of Silicon Labs, will oversee Malaysia manufacturing as the company targets high-volume production. The move comes after Marvell canceled Celestial AI orders, which had weighed on the stock. Broader tech indices fell Tuesday, but POET shares outperformed.
IREN Stock Slips as Nvidia Deal Runs Into the Price of Building AI Capacity

IREN Stock Slips as Nvidia Deal Runs Into the Price of Building AI Capacity

12 May 2026
IREN shares fell about 2.4% to $53.80 Tuesday after the company priced an upsized $2.6 billion convertible-note sale, raising concerns over funding costs and dilution. The notes carry a 1% coupon and can convert at $73.07 per share. IREN reported a $247.8 million net loss last quarter. Peers Cipher Digital, Riot Platforms, and Marathon Digital also traded lower.

Popular

Tech News Deep Dive: July 7, 2025 / Updated: 2025, July 7th, 00:00 CET

Tech News Deep Dive: July 7, 2025 / Updated: 2025, July 7th, 00:00 CET

7 July 2025
Nintendo Switch 2 launched in June 2025 with upgraded hardware, but Mario Kart World drew criticism for limited multiplayer and lack of innovation. Raphael Colantonio called Xbox Game Pass unsustainable as Microsoft shut down The Initiative and canceled Perfect Dark and Forza Motorsport. Stardew Valley reached 41 million sales and a 98.4% Steam rating. The James Webb Space Telescope captured a direct image of exoplanet 14 Herculis c.
CoreWeave stock price tumbles as $35 billion capex plan rattles investors
Previous Story

CoreWeave stock price tumbles as $35 billion capex plan rattles investors

Sandisk stock price slides on insider sale filing; SNDK faces key dates next week
Next Story

Sandisk stock price slides on insider sale filing; SNDK faces key dates next week

Go toTop